Splenic Surgery for Hydatid Spleen in Single Institutional Experience

Sponsor
Jabir Ibn Hayyan Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04890899
Collaborator
(none)
10
77.2

Study Details

Study Description

Brief Summary

Splenic-preserving surgery in hydatid spleen: Single intuitional experience

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cystic enculation of spleen hydatid

Detailed Description

Background:

Although hydatid disease affects many organs in the human body, splenic hydatid represents about 0.8-4% of all human echinococcosis cases. Until recently, splenectomy was the recommended surgical procedure for splenic hydatid. Since 1980 there has been an increasing tendency to use conservative option to deal with such pathology.

Aim of the study:

To evaluate our experience in open splenic-preserving surgery for splenic hydatid in a single institutional study.

Patient and methods:

A retrospective study. Ten patients with splenic hydatid were operated upon from August 2013 to January 2018 in our medical centre. Spleen has affected alone in 7 cases, liver and spleen were affected in 3 cases, and one of them had intraperitoneal cyst affection in addition. The diagnosis confirmed mainly by ultrasonography. In some cases, it computed tomography CT scan, and magnetic resonance imaging MRI were needed. Chest X-ray had taken for all patients to exclude pulmonary hydatid. The open surgical procedure used. Isolation of the field, aspiration of cystic fluid and injection of 1% cetrimide solution, re-aspiration, endocystectomy, suturing of cystic edges over intracystic tube drain. All surgery did under cover of albendazole pre and postoperative 15mg/kg/day.

Results:

No significant intraoperative and postoperative complications. No reoperation was needed. Hospital stays 3-5 days. No recurrence after (1-3) year follow-up. However, three patients missed follow-up after two years.

Conclusion:

Our experience in splenic hydatid encourages us to use splenic-preserving surgery whenever possible instead of splenectomy.

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Splenic Preserving Surgery in Hydatid Spleen
Actual Study Start Date :
Aug 20, 2013
Actual Primary Completion Date :
Jan 19, 2018
Actual Study Completion Date :
Jan 25, 2020

Outcome Measures

Primary Outcome Measures

  1. splenic sparing surgery for hydatid spleen [3 year]

    Six of them males and four females, their age range from 5- 40 years (mean 23.6 years). Hydatid spleen alone was found in seven cases while splenic and liver hydatid was found in three cases one of them had peritoneal hydatid affection in addition. Hospital stay was ranged from 3-5 days.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Single hydatid spleen Primary spleen hydatid

-

Exclusion Criteria:
  • Multiple splenic hydatid Rupture hydatid spleen

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Jabir Ibn Hayyan Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jabir Ibn Hayyan Medical University
ClinicalTrials.gov Identifier:
NCT04890899
Other Study ID Numbers:
  • JabirIbnHayyanMU
First Posted:
May 18, 2021
Last Update Posted:
May 18, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jabir Ibn Hayyan Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2021